ebola
virus
ebov
identifi
emerg
threat
recent
year
caus
sever
haemorrhag
fever
human
epitopebas
vaccin
design
ebov
remain
top
prioriti
mere
progress
made
regard
anoth
reason
lack
antivir
drug
licens
vaccin
although
sever
outbreak
central
africa
studi
aim
design
epitopebas
vaccin
trigger
signific
immun
respons
well
prognost
inhibitor
bind
potenti
drug
target
site
use
variou
immunoinformat
dock
simul
tool
capac
induc
humor
cellmedi
immun
cell
b
cell
check
select
protein
peptid
region
span
amino
acid
sequenc
tlasigtaf
found
potenti
b
cell
epitop
respect
peptid
could
interact
hla
show
high
popul
coverag
use
molecular
dock
epitop
apprais
bind
hla
molecul
verifi
bind
cleft
interact
addit
allergen
epitop
also
evalu
posttherapeut
strategi
dock
studi
predict
structur
identifi
suitabl
therapeut
inhibitor
target
protein
howev
comput
epitopebas
peptid
vaccin
design
target
site
predict
ebov
open
new
horizon
may
prospect
way
ebola
virus
research
result
requir
valid
vitro
vivo
experi
curs
ebola
viru
new
almost
sever
decad
older
disast
caus
ebola
viru
sever
ever
may
becom
even
wors
pay
proper
attent
ebola
virus
ebov
belong
filovirida
famili
negativestrand
rna
nonseg
envelop
virus
respons
caus
fatal
haemorrhag
fever
human
nonhuman
primat
fatal
rate
ebola
viru
infect
human
character
immedi
onset
flulik
ill
follow
preliminari
incub
period
day
initi
period
infect
sign
symptom
diseas
becam
promin
includ
nausea
anorexia
chest
pain
vomit
neurolog
complic
cough
oedema
postur
hypotens
mucos
haemorrhag
transmiss
ebov
occur
among
human
nonhuman
primat
chimpanze
gorilla
direct
contact
infect
bodili
fluid
blood
infect
person
anim
even
intent
releas
ebov
may
also
caus
mucos
infect
aerosol
dispers
five
differ
strain
ebov
identifi
sudan
sebov
ivori
coast
zair
zebov
reston
recent
identifi
strain
bundibugyo
among
sebov
zebov
consid
commonli
occur
infect
highest
number
death
current
occurr
ebola
viru
report
guinea
decemb
afterward
spread
liberia
sierra
leon
nigeria
unpredict
size
scale
current
outbreak
capabl
destabil
alreadi
delic
economi
health
care
wildtyp
filoviru
infect
consid
deadli
one
mortal
rate
high
human
case
high
mortal
rate
defici
treatment
vaccin
make
ebola
viru
potenti
public
enemi
categori
biothreat
pathogen
sever
attempt
made
develop
effect
vaccin
ebola
viru
due
reoccurr
deadli
natur
ideal
vaccin
initi
humor
cellmedi
immun
respons
essenti
complet
erad
chanc
reinfect
vaccin
design
method
base
cell
epitop
character
recognit
immunedomin
epitop
viru
synthes
util
vaccin
induc
effect
immun
respons
assess
enhanc
possibl
ideal
vaccin
candid
computerbas
predict
tool
reduc
number
valid
experi
time
epitop
predict
number
epitop
predict
tool
avail
web
bioinformaticsbas
predict
ctl
epitop
gain
huge
popular
drug
design
develop
activ
convent
vaccin
usual
prepar
base
either
attenu
inactiv
whole
pathogen
approach
number
limit
among
safeti
fundament
problem
pathogen
util
vaccin
may
revert
pathogen
form
caus
infect
moreov
genet
variat
pathogen
globe
may
result
reduc
effici
vaccin
differ
part
world
vaccin
design
methodolog
dna
vaccin
epitopebas
vaccin
capabl
overcom
obstacl
develop
vaccin
initi
effect
specif
strong
longlast
immun
respons
minim
cost
side
effect
method
epitopebas
vaccin
develop
report
rhinoviru
dengu
viru
human
coronavirus
chikungunya
viru
saint
loui
enceph
viru
although
epitopebas
vaccin
develop
base
b
cell
epitop
potenti
cell
epitopebas
vaccin
also
promis
cell
induc
effect
immun
respons
host
cell
infect
cell
variou
potenti
vaccin
candid
develop
base
ebovgp
success
exhibit
protect
nonhuman
primat
ebola
viruslik
particl
replicationdefici
adenoviru
express
ebovgp
replicationcompet
vesicular
stomat
viru
express
ebovgp
recombin
paramyxoviru
express
ebovgp
mani
ebola
vaccin
candid
develop
decad
prior
none
yet
approv
clinic
use
human
two
vaccin
candid
current
test
human
vaccin
develop
glaxosmithklin
collabor
unit
state
nation
institut
allergi
infecti
diseas
rvsvzebov
vaccin
develop
new
link
genet
merck
vaccin
usa
collabor
public
health
agenc
canada
vaccin
shown
safe
efficaci
anim
present
studi
attempt
recogn
major
immunogen
epitop
ebola
viral
protein
predict
vaccin
well
effect
inhibitor
bind
site
simultan
also
perform
genomewid
search
recogn
suitabl
drug
target
site
simul
inhibit
target
site
predict
inhibitor
molecul
util
bioinformat
tool
studi
enhanc
futur
laboratorybas
attempt
develop
effect
treatment
prevent
ebola
viru
infect
flow
chart
repres
overal
procedur
peptid
vaccin
develop
target
site
depict
ebola
viru
illustr
fig
complet
proteom
ebov
amino
acid
sequenc
retriev
use
uniprot
knowledg
base
uniprotkb
databas
fasta
format
exclud
variabl
region
uniprotkb
defin
exclus
protein
sequenc
annot
inform
server
provid
function
inform
protein
accuraci
consist
number
nonstructur
protein
nsp
expel
select
analys
sequenc
conduct
studi
antigen
solventaccess
region
surfac
access
flexibl
mhc
classi
bind
site
protein
submit
vaxijen
server
util
predict
effect
antigen
subunit
vaccin
use
default
paramet
plain
sequenc
format
upload
viru
chosen
target
organ
antigen
protein
sort
accordingli
relev
score
excel
file
one
antigen
protein
highest
antigen
score
select
carri
evalu
constant
predict
ctl
epitop
essenti
design
coher
vaccin
purpos
internetbas
server
devis
identifi
human
ctl
epitop
target
protein
use
total
score
calcul
sum
valu
tap
transport
effici
proteasom
cleavag
mhci
molecul
bind
affin
present
studi
set
paramet
sensit
specif
respect
five
highest
score
contain
epitop
select
dri
laboratori
experiment
ic
valu
determin
bind
affin
peptid
mhci
molecul
calcul
util
stabil
matrix
base
method
smm
frequent
nonfrequ
allel
peptid
length
default
amino
acid
prior
predict
valid
select
allel
less
nm
bind
affin
ic
calcul
process
score
tap
score
proteasom
cleavag
score
mhci
bind
affin
addit
iedb
analysi
resourc
tool
also
use
also
implement
smm
tool
predict
score
everi
singl
select
peptid
epitop
conserv
predict
epitop
calcul
use
iedb
analysi
resourc
use
iedb
popul
coverag
tool
popul
coverag
individu
epitop
calcul
everi
epitop
mhci
molecul
ad
popul
coverag
area
also
select
earlier
submiss
allerhunt
onlin
server
implement
predict
allergen
select
epitop
server
predict
allergen
util
combin
predict
method
combin
allergen
assess
protocol
food
agricultur
organ
fao
world
health
organ
follow
support
vector
machin
svm
pairwis
sequenc
similar
allerhunt
predict
allergen
nonallergen
high
specif
contribut
allerhunt
comprehens
tool
allergen
crossreact
predict
make
stronger
allerhunt
predict
allergen
also
check
anoth
onlin
tool
name
allertop
http
wwwddgpharmfacnetallertop
highest
conserv
tlasigtaf
epitop
submit
pepfold
server
conduct
dock
simul
studi
provid
probabl
structur
best
model
taken
studi
interact
hla
dock
analysi
conduct
ensur
interact
hla
molecul
target
epitop
implement
autodockvina
retriev
crystal
structur
hlab
rcsb
databas
perform
dock
analysi
perform
dock
analysi
epitop
influenza
form
complex
hlab
bind
groov
elimin
util
discoveri
studio
first
dock
studi
predict
epitop
prepar
hlab
perform
follow
influenza
epitop
prepar
hlab
b
cell
epitop
predict
tool
iedb
use
predict
linear
b
cell
epitop
base
highest
immunogen
protein
sequenc
import
properti
predict
b
cell
epitop
flexibl
antigen
surfac
access
hydrophil
linear
epitop
predict
analys
flexibl
antigen
surfac
access
hydrophil
linear
epitop
predict
select
highest
antigen
protein
use
karplu
schulz
flexibl
predict
kolaskar
tongaonkar
antigen
scale
emini
surfac
access
predict
parker
hydrophil
predict
bepipr
linear
epitop
predict
algorithm
respect
iedb
analysi
resourc
number
wet
laboratori
studi
state
antigen
portion
locat
betaturn
region
protein
chou
fasman
betaturn
predict
method
util
analys
region
assess
differ
physiolog
chemic
characterist
select
protein
sever
tool
protparam
selfoptim
predict
method
align
sopma
expasi
server
util
isoelectr
point
pi
molecular
weight
amino
acid
composit
grand
averag
hydropath
gravi
estim
halflif
extinct
coeffici
instabl
index
aliphat
index
protein
calcul
use
default
paramet
protparam
properti
solvent
access
globular
region
transmembran
helic
random
coil
bend
region
coiledcoil
region
anticip
sopma
function
analysi
protein
special
tool
pfp
kihara
bioinformat
laboratori
http
kiharalaborgwebpfpphp
use
retriev
amino
acid
sequenc
fasta
format
use
input
data
globplot
http
globplotembld
use
predict
diseasecaus
region
model
hhpred
implement
predict
threedimension
structur
select
protein
fasta
format
data
submit
intens
model
option
select
yield
protein
model
modrefin
use
refin
homolog
predict
protein
structur
current
studi
refin
perform
sever
time
get
better
minim
protein
energi
lastli
protein
visual
swisspdb
viewer
assess
accuraci
stereochem
properti
predict
model
procheck
perform
ramachandran
plot
analysi
util
protein
structur
model
assess
tool
swissmodel
workspac
refin
pdb
format
protein
submit
resolut
valu
select
protein
structur
assess
profil
predict
protein
model
qualiti
estim
perform
errat
qmean
respect
paramet
kept
default
evalu
tool
activ
site
analysi
give
clear
percept
dock
simul
studi
activ
bind
site
protein
search
accordingli
structur
associ
templat
model
construct
castp
comput
atla
surfac
topographi
protein
server
util
identifi
determin
bind
site
surfac
structur
pocket
intern
caviti
protein
activ
site
area
shape
volum
everi
pocket
measur
hydrophob
desir
protein
sequenc
also
repres
mani
biophys
consequ
exampl
proteinprotein
proteinligand
bind
play
import
role
drug
design
discoveri
studio
client
http
accelryscomproduct
discoverystudio
employ
regard
epitopebas
peptid
vaccin
design
result
queri
ebola
viru
structur
nonstructur
protein
hit
gener
total
protein
assess
vaxijen
server
capabl
protein
sequenc
initi
immun
respons
indic
overal
score
produc
specif
protein
sequenc
use
vaxijen
server
protein
sequenc
uniprotkb
id
achiev
highest
score
vaxijen
analysi
among
queri
protein
protein
name
l
protein
compris
amino
acid
also
known
rnadepend
rna
polymeras
present
studi
select
protein
carri
analysi
netctl
server
util
predict
cell
epitop
protein
first
epitop
veiktgfkl
gfklrsavm
arvaaslak
tsacgiflk
tlasigtaf
select
accord
highest
combinatori
score
base
iedb
mhc
bind
predict
tool
previous
select
epitop
found
identifi
rang
mhc
molecul
studi
opt
select
mhci
molecul
coupl
ic
valu
less
nm
ic
ensur
select
mhci
molecul
tabl
select
epitop
show
higher
affin
mhci
process
effici
tool
iedb
gener
overal
score
everi
epitop
accordingli
proteasom
cleavag
effici
tap
transport
effici
mhci
bind
effici
combin
combin
score
repres
potenti
peptid
present
higher
score
better
crucial
step
initi
success
immun
respons
score
obtain
iedb
mhci
bind
analysi
process
tool
summar
tabl
identif
epitop
hla
molecul
combin
effect
determin
intens
immun
respons
peptid
recogn
highest
number
hla
allel
possess
highest
potenti
initi
strong
immun
respons
among
epitop
studi
one
epitop
interact
higher
number
hla
allel
epitop
epitop
tlasigtaf
show
affin
highest
conserv
epitop
give
success
immun
therefor
better
conserv
epitop
expect
epitop
conserv
analysi
expos
tabl
epitop
arvaaslak
conserv
wherea
epitop
tlasigtaf
score
three
epitop
veiktgfkl
gfklrsavm
tsacgiflk
show
conserv
respect
everi
epitop
mhci
binder
recogn
optimum
select
popul
coverag
analysi
identifi
optimum
mhci
binder
epitop
consid
popul
coverag
analysi
epitop
epitop
indic
coverag
west
africa
along
coverag
central
africa
north
africa
respect
recent
ebola
virusinfect
area
uganda
sudan
mali
epitop
reveal
popul
coverag
respect
popul
coverag
analysi
select
epitop
tabul
tabl
queri
sequenc
meet
standard
set
faowho
evalu
scheme
crossreact
allergen
predict
result
queri
sequenc
consid
nonallergen
faowho
evalu
scheme
allerhunt
reveal
queri
sequenc
nonallergen
score
se
sp
contrast
allertop
disclos
select
sequenc
probabl
allergen
probabl
food
inhal
tabl
potenti
cell
epitop
interact
mhci
allel
total
process
score
epitop
conserv
result
interact
mhci
allel
affin
total
score
proteasom
score
tap
score
mhc
score
process
score
mhci
bind
evalu
five
initi
chosen
epitop
found
epitop
tlasigtaf
ideal
one
vaccin
candid
epitop
consid
overal
epitop
conserv
popul
coverag
affin
highest
number
hla
molecul
autodockvina
predict
bind
mode
epitop
tlasigtaf
hla
molecul
conduct
analysi
first
retriev
hlab
attach
influenza
epitop
crystal
structur
dock
simul
perform
epitop
elimin
hla
molecul
bind
energi
predict
epitop
hlab
receptor
found
kcalmol
bind
energi
influenza
epitop
compar
hlab
epitop
kcalmol
structur
shown
fig
hla
epitop
visual
captur
pymol
molecular
graphic
system
version
queri
protein
evalu
identifi
b
cell
epitop
variou
onlin
tool
avail
iedb
kolaskar
tongaonkar
antigen
predict
tool
evalu
protein
b
cell
epitop
analys
physicochem
properti
amino
acid
profus
recogn
b
cell
epitop
tool
provid
result
predict
averag
antigen
propens
valu
protein
maximum
valu
minimum
tool
tag
target
valu
scan
antigen
potent
region
region
show
desir
b
cell
epitop
properti
surfac
access
b
cell
epitop
essenti
hydrophil
region
usual
expos
surfac
like
initi
b
cell
immun
respons
emini
surfac
access
predict
parker
hydrophil
predict
tool
util
highest
surfac
access
region
amino
acid
sequenc
hand
hydrophil
region
amino
acid
sequenc
betaturn
protein
usual
surfac
access
exhibit
hydrophil
natur
chou
fasman
betaturn
predict
perform
protein
find
betaturn
region
queri
protein
betaturn
import
consequ
initi
antigen
gener
outcom
recogn
region
constant
predict
bturn
region
flexibl
region
queri
protein
recogn
use
karplu
schulz
flexibl
predict
tool
region
consider
favour
region
flexibl
predict
analysi
linear
b
cell
epitop
determin
util
bepipr
machin
learn
process
base
hidden
markov
model
region
also
favour
region
bepipr
linear
epitop
predict
crossprocess
data
obtain
previou
b
cell
epitop
predict
tool
region
amino
acid
found
best
capabl
region
induc
b
cell
respons
overal
result
b
cell
epitop
analysi
repres
figur
structur
featur
function
protein
interrel
protparam
gener
result
provid
instabl
index
ii
aliphat
index
neg
gravi
grand
averag
hydropathi
protein
sopma
calcul
secondari
structur
featur
protein
report
protein
domin
alphahelix
consist
random
coil
extend
strand
form
protein
respect
lastli
show
betaturn
constitut
paramet
calcul
tool
shown
tabl
respect
function
protein
studi
predict
pfp
kihara
bioinformat
laboratori
use
tabl
result
globplot
use
identifi
three
diseasecaus
region
figur
structur
ebola
l
protein
predict
util
model
model
gener
model
refin
modrefin
acquir
stereochem
precis
model
refin
model
demonstr
residu
protein
favour
region
refin
model
util
perform
subsequ
analysi
swisspdb
gener
view
model
display
figur
predict
model
present
studi
valid
determin
accuraci
compar
highresolut
model
variou
structur
valid
tool
procheck
conduct
overal
analysi
model
gener
ramachandran
plot
shown
figur
tabl
verif
tool
qmean
gener
environment
profil
graph
given
protein
perform
verif
protein
model
respect
activ
site
ebov
l
protein
shown
fig
identifi
castp
server
measur
outcom
indic
amino
acid
posit
predict
conserv
activ
site
server
predict
best
activ
site
area
form
amino
acid
residu
facilit
drug
discoveri
ebola
virus
hydrophob
depict
figur
stand
strong
hydrophob
natur
desir
protein
sequenc
cell
epitopebas
vaccin
distinct
approach
despit
fact
antibodi
memori
respons
easili
avoid
antigen
drift
period
time
cellmedi
immun
frequent
elicit
endur
immun
signific
number
time
money
alreadi
spent
ebovsvaccin
design
howev
littl
achiev
show
believ
although
step
forward
made
regard
brought
promis
clinic
trial
standpoint
worth
tri
attempt
good
peptid
epitop
particular
sequenc
poss
key
properti
firstli
epitop
fairli
well
conserv
among
ebov
proteom
addit
epitop
must
qualiti
make
sure
process
moreov
process
peptid
abl
relat
mhc
allel
high
affin
lastli
interact
mhc
allel
gener
confirm
good
popul
coverag
predict
cell
epitop
fulfil
criteria
mention
five
prospect
cell
epitop
found
ebov
l
protein
crossreact
hla
variant
hlaa
hlab
hlac
allel
predict
cell
epitop
tlasigtaf
well
conserv
among
five
probabl
epitop
select
netctl
cell
epitop
analysi
epitopebas
vaccin
develop
wellconserv
epitop
expect
express
higher
protect
across
differ
strain
conserv
select
epitop
consequ
regard
univers
epitop
target
popul
coverag
anoth
key
factor
develop
peptid
vaccin
measur
percentag
peopl
live
given
area
potenti
respons
queri
epitop
epitop
subject
allergen
analysi
two
onlin
tool
allerhunt
point
nonallergen
although
allertop
identifi
probabl
allergen
therefor
epitop
vaccin
develop
util
select
peptid
probabl
allerg
reaction
low
anoth
concern
epitop
design
base
predict
might
effort
realiti
select
epitop
subject
silico
dock
simul
studi
dock
analysi
conclud
select
epitop
bind
compet
control
consid
regard
ebov
l
protein
also
search
b
cell
epitop
induc
primari
secondari
immun
crossreferenc
sever
tool
iedb
gener
result
found
favour
region
peeqeqsa
potent
b
cell
epitop
posttherapeut
strategi
insight
attain
primari
secondari
structur
analysi
protein
protparam
sopma
tool
l
protein
suggest
vaxijen
found
stabl
vitro
instabl
index
low
gravi
higher
aliphat
index
higher
proport
coil
region
sopma
analysi
implic
stabil
select
protein
algorithm
call
pfp
kihara
bioinformat
laboratori
globplot
use
function
character
disord
region
identif
assist
futur
drug
design
drug
discoveri
ligand
bind
site
hydrophob
analysi
perform
hydrophob
impact
everi
aspect
drug
design
even
deliveri
repeatedli
point
past
centuri
understand
exploit
hydrophob
effect
drug
design
exampl
dock
target
structur
predict
undoubtedli
import
futur
develop
effect
therapeut
ebola
viru
remain
high
prioriti
consider
improv
made
last
year
howev
still
need
know
lot
biolog
pathogenesi
ebola
viru
infect
identifi
suitabl
vaccin
keep
fact
mind
present
studi
use
comput
bioinformat
tool
tri
identifi
novel
therapeut
vaccin
besid
target
site
studi
treatment
ebola
viru
previous
establish
procedur
b
cell
cell
epitop
identifi
could
breakthrough
develop
new
therapeut
diagnost
tool
howev
also
recommend
vivo
vitro
assess
vaccin
perform
confirm
studi
addit
support
inform
may
found
onlin
version
articl
figur
b
cell
epitop
identif
antigen
protein
figur
globplot
result
present
diseasecaus
region
rnadepend
rna
polymeras
figur
swisspdb
gener
structur
ebov
rnadepend
rna
polymeras
figur
ramachandran
plot
analysi
red
region
indic
favour
region
yellow
region
allow
light
yellow
show
gener
allow
region
white
disallow
region
phi
psi
angel
determin
torsion
angel
figur
hydrophob
plot
analysi
